Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure

By Shapiro Charles   Phillips Gary   Poznak Catherine   Jackson Rebecca   LeBoff Meryl   Woodard Stacy   Lemeshow Stan  

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 41-46

Springer Publishing Company

Access to resources Recommend Favorite

Clodronate as a Single-dose Intravenous Infusion Effectively Provides Short-term Correction of Malignant Hypercalcemia

By Atula Sari T.   Tähtelä Riitta K.   Nevalainen Jaakko I.   Pylkkänen Liisa H.  

Acta Oncologica, Vol. 42, Iss. 7, 2003-11 ,pp. : 735-740

Informa Healthcare

Access to resources Recommend Favorite

Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure

By Breedlove Hollie   Smith Anne   Burk Raymond   Hill Kristina   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 225-230

Springer Publishing Company

Access to resources Recommend Favorite

What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?

By Breed Wim  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 3-5

Springer Publishing Company

Access to resources Recommend Favorite